节点文献

黄芩苷及三七总皂苷配伍脑脊液药代动力学研究

Pharmacokinetic studies of baicalin and compatibility of baicalin-Panax Notoginsenosides in rat cerebrospinal fluid

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 杨雁芳李智王磊王永炎张文生

【Author】 YANG Yan-fang1,2,4,LI Zhi1,3,4,WANG Lei1,3,4,WANG Yong-yan1,3,4,ZHANG Wen-sheng1,3,4(1.State Key Laboratory of Earth Surface Processes and Resource Ecology,Beijing Normal University,Beijing 100875,China; 2.School of Pharmaceutical Science,Peking University,Beijing 100191,China; 3.Beijing Area Major Laboratory of Protection and Utilization of Traditional Chinese Medicine,Beijing 100875,China; 4.Center for Natural Medicine Engineering,Ministry of Education,Beijing 100875,China)

【机构】 北京师范大学地表过程与资源生态国家重点实验室北京大学药学院天然药物教育部工程研究中心

【摘要】 目的建立大鼠脑脊液中黄芩苷的HPLC-MS/MS测定方法,研究黄芩苷及配伍三七总皂苷的大鼠脑脊液药代动力学变化。方法大鼠尾静脉注射黄芩苷和黄芩苷-三七总皂苷配伍溶液,采集脑脊液样品,利用LC-MS/MS测定脑脊液中黄芩苷的含量。色谱柱为Agilent Eclipse XDB-C18(4.6 mm×150 mm,5μm),流动相为乙腈:1 mmol·L-1乙酸铵(含0.1%甲酸):0.1%氨水梯度洗脱;质谱检测离子为m/z 445/269(黄芩苷[M-1]-),m/z 237/194(卡马西平[M+1]+)。结果在5~200μg·L-1范围内,黄芩苷与内标卡马西平的峰面积比值与浓度的线性关系良好,回收率为87.15%~92.73%。黄芩苷在单独给药组和三七总皂苷配伍组的药代动力学参数分别为:Cmax为(189.67±20.13)、(237.00±51.86)μg·L-1,AUC0-t为(6612.96±1023.65)、(5466.63±267.06)μg·min·L-1,AUC0-∞为(6930.43±1060.41)、(5682.13±412.79)μg·min·L-1,T12为(108.84±45.67)、(102.54±38.37)min,CL为(15.39±2.60)、(18.32±0.88)L·min-1·kg-1。结论建立的HPLC-MS/MS测定方法能够准确灵敏地测定脑脊液中的黄芩苷。黄芩苷能够透过血脑屏障进入大鼠脑脊液,合用三七总皂苷后黄芩苷的药代动力学参数无明显变化,说明三七总皂苷对黄芩苷的脑脊液代谢没有明显影响。

【Abstract】 Aim To establish a HPLC-MS-MS method for the determination of baicalin in rat cerebrospinal fluid(CSF) and investigate the pharmacokinetics of baicalin and compatibility with Panax Notoginsenosides(PNS).Methods After baicalin and compatibility of BA-PNS were given by intravenous administration,the concentration of baicalin in rat CSF was determined by HPLC-MS-MS.Chromatographic separation was performed on an Agilent Eclipse XDB-C18(4.6 mm×150 mm,5 μm) within 7 min,with the mobile gradientphase of acetonitrile:1mmol·L-1 ammonium acetate(containing 0.1% formic acid): 0.1% ammonia.The target ion transitions were m/z 445/269(baicalin-) and m/z 237/194(Carbamazepine +).Results Calibration curves were linear over the concentration range from 5~200 μg·L-1for baicalin,with the recovery rates between 87.15%~92.73%.The pharmacokinetic parameters after a single dose of baicalin and baicalin-PNS were as follows: Cmax:(189.67±20.13),(237.00±51.86) μg·L-1;AUC0-t:(6612.96 ±1023.65),(5466.63±267.06) μg·min·L-1;AUC0-∞(6930.43±1060.41),(5682.13±412.79) μg·min·L-1;T1[]2:(108.84±45.67),(102.54±38.37) min;CL:(15.39±2.60),(18.32±0.88) L·min-1·kg-1.Conclusion The method is proved to be accurate and convenient to determine baicalin in rat cerebrospinal fluid.Baicalin can pass through blood-brain barrier and enter the cerebrospinal fluid.The pharmacokinetic parameters of baicalin have not changed,so PNS has no effect on the CSF pharmacokinetic of baicalin.

【基金】 国家自然科学基金资助项目(No 81072723);国家“重大新药创制”科技重大专项(No 2012ZX09103-201);北京市支持中央在京高校共建项目(No 403105)
  • 【文献出处】 中国药理学通报 ,Chinese Pharmacological Bulletin , 编辑部邮箱 ,2012年07期
  • 【分类号】R285.5
  • 【被引频次】13
  • 【下载频次】751
节点文献中: 

本文链接的文献网络图示:

本文的引文网络